Related Experiment Video
Updated: Mar 24, 2026
12:00
Preparation and Characterization of SDF-1α-Chitosan-Dextran Sulfate Nanoparticles
Published on: January 22, 2015
13.0K
Chitosan: An Adjuvant with an Unanticipated STING
1Immunobiology Section, Laboratory of Parasitic Diseases, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Immunity
|March 17, 2016
Summary
Chitosan, a polysaccharide adjuvant, unexpectedly activates the DNA sensing cyclic GMP-AMP synthase (cGAMP) synthase (cGAS)-stimulator of interferon genes (STING) pathway. This pathway is crucial for triggering innate signals that promote adaptive immunity.
Area of Science:
- Immunology
- Innate Immunity
- Adaptive Immunity
Background:
- Adjuvants enhance adaptive immune responses by activating innate immune signals.
- The precise mechanisms by which adjuvants trigger these innate signals are not fully understood.
- The cyclic GMP-AMP synthase (cGAMP) synthase (STING) pathway is a key component of innate immune sensing.
Purpose of the Study:
- To investigate the underlying mechanisms of action for the polysaccharide adjuvant chitosan.
- To determine the role of innate immune sensing pathways in chitosan-mediated adjuvant effects.
- To elucidate how chitosan promotes Th1 cell responses.
Main Methods:
- Investigated the interaction of chitosan with immune cells.
- Utilized genetic and pharmacological approaches to modulate the cGAS-STING pathway.
- Assessed immune cell activation and cytokine production in response to chitosan.
Main Results:
- Chitosan was found to unexpectedly activate the DNA sensing cGAS-STING pathway.
- Activation of the cGAS-STING pathway by chitosan was critical for its ability to promote Th1 cell responses.
- This highlights a novel mechanism for adjuvant action.
Conclusions:
- The cGAS-STING pathway plays a previously unrecognized role in the adjuvant activity of chitosan.
- Understanding this pathway provides new insights into the development of more effective vaccine adjuvants.
- This discovery opens avenues for targeted adjuvant design to enhance adaptive immunity.
